A Study of ABSK061 to Assess Safety, Tolerability, Pharmacokinetics, and Efficacy in Children With Achondroplasia
Clinical trial NCT07297875 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07297875
- Sponsor
- Abbisko Therapeutics Co, Ltd
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-10
- Primary completion
- 2028-12-15
- Enrollment
- 110
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.